Nepal Case Study International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012 Bishnu D. Paudel, MD Nepal.

Slides:



Advertisements
Similar presentations
Prepared by : Dr. Purvi Bhagat From : Guidelines of Gujarat Medical Council – Continuing Medical Education in the State of Gujarat.
Advertisements

International Palliative Care Network Lecture Series 2013
The NHS Reforms – a Policy Analyst’s View
REDUCING CODEINE COUGH SYRUP MEDICINE CONSUMPTION TO CONTROL CODEINE ABUSE IN THAILAND Naiyana Patcharapisarn Narcotics Control Division Food and Drug.
Country Report for: ALBANIA DR. KRISTO HUTA. 2 Demographic Dat a Albania: Population Albania: Population »Year 1990: inhabitants. »Year 1990:
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School.
Inaugural Conference of the African Health Economics and Policy Association (AfHEA) Accra - Ghana, 10th - 12th March 2009 Patent medicines vendors a resource.
Yuki Takao IGHI Student Challenges Competition 2013 – 27 th November Supervisor: Prof. Mark Thursz BARRIERS TO END OF LIFE CARE IN THE GAMBIA: How can.
Improving access to opioid analgesics: Ukraine March 5-6, 2013 Vienna.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
Action Plan India Priya, Nandini, Shalini, Dr. Sudhir, Rajesh, Raj, Frank, David.
The Estimation of National Opioid Requirements: New INCB/WHO Guidelines International Pain Policy Fellowship Training Session Madison, Wisconsin, USA 8.
National Mental Health Programme. Govt of India integrated mental health with other health services at rural level. It is being implemented since 1982.
Emergency Medicine in Jordan Rashed Hijazi MD, FRCSEd (A&E) Consultant EM.
Perspectives of Former International Pain Policy Fellows International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012 Bishnu.
Abuse Liability of Hydromorphone Extended Release Capsules Silvia N. Calderon, Ph.D. Controlled Substance Staff Center for Drug Evaluation and Research.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan.
Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Supplies by pharmacists to entities other than patients.
Opioid Workshop on National Drug Control Policy: “Opioids – the foundation of pain treatment” Translating barriers into Action WORKING WITH GOVERNMENT.
International Pain Policy Fellowship, Cohort III
March года Barcelona, Spain Tajikistan country presentation.
International Marketing Chapter 15
Research Activities to Document Progress During IPPF Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies Group.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
Country Report for: UKRAINE Natallia Datsiuk, MPH Bogomolets National Medical University Ukraine, Kyiv.
Patient Protection and Affordable Care Act March 23, 2010.
Understanding and Using INCB Opioid Consumption Statistics: Including Morphine Equivalence 8 August 2012 Martha Maurer, MSW, MPH, PhD Pain & Policy Studies.
“Improving opioid availability through advocacy” Experience from Serbia Snežana Bošnjak International Pain Policy Fellow ( ) Institute for Oncology.
Ministry of Health of the Republic of Armenia Feb 2013.
Global Access to Pain Relief Initiative (GAPRI) Meg O’Brien 1 Market Forecast in Eastern Europe and Central Asia March 2013.
Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Country Report for:
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
UICC WORLD CONGRESS: UICC WORLD CANCER CONGRESS 2006 JULY 8-12 TH, WASHINGTON, D.C. WORKING WITH GOVERNMENT AND NURSING TO EXTEND PAIN RELIEF TO THE PERIPHERY.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Tajikistan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Meg O’Brien, Ph.D. Director, Global Access to Pain Relief Initiative Procurement & Manufacture of IR Oral Morphine: Uganda experience 1.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
PATIENT CASE Module 4 Date of preparation: June 2015 HQ/EFF/15/0024h.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Provide the right care for each patient at the right time in the right care setting Transitions in Care: Caring for our Patients Connecting our Partners.
"Perspectives of former International Pain Policy Fellows" Prof. Snežana Bošnjak, MD, PhD Institute for Oncology and Radiology of Serbia (IORS) Belgrade,
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
“Early to Rise, Early to Home” Standing Patients on Day of Surgery Trish Davidson, PT Langley Memorial Hospital.
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
Marketing Career Project Renee Bass Pharmaceutical/Medical Marketing.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
SANJEEVANI PVT LTD Name: Shibani Bordia. ROADMAP Introduction Products and its market Formalities Procedure Finance.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
*Risk Evaluation and Mitigation Strategy
TB- HIV Collaborative activities in Romania- may 2006 status
Psychotropic Substances Rules, 1985
Conference Series LLC Conferences
Opioid Availability and Palliative Care in Nepal: Influence of an International Pain Policy Fellowship  Bishnu Dutta Paudel, MBBS, MD, Karen M. Ryan,
AIKTC - School of Pharmacy
Intrathecal Drug Delivery
Situation analysis in Kyrgyzstan
Presentation transcript:

Nepal Case Study International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012 Bishnu D. Paudel, MD Nepal

The Lord Buddha born in 623 B.C

Nepal 2/3 rd Cancer are in advanced stage Pain was most common symptom in these advanced cancer patients.

Penis Cancer Cancer in advanced stage

2008 in Nepal Pain was not treated optimally due to multiple reasons. Unavailability of opioids was most important cause. No morphine syrup Morphine Tablet supply was irregular

International Pain Policy Fellowship 2008 Ministry of Health Representative International Pain Policy Fellow

Barriers of opioid availability 1) Policy 2) Drug Distribution System 3) Cost of Opioid Analgesics 4) Knowledge & Attitudes

Drug Distribution System Collaboration with different people including importers to improve opiod availability by timely reporting and proper action

Dear Dr. Paudel, 1) Order and the permission to import Morphine tablets granted to the overseas buyer by the Drug Control authority of the country is send to the concerned Manufacturing unit. 2) Based on the ordered quantity, the requirement of active drug Morphine Sulphate is worked out and a separate application for allotment of quota of Narcotic Drug (Morphine Sulphate) is made to the State Drug Control authority. (period 45 to 60 days subject to availability of material) 3) The necessary allotment is given after scrutiny of the application for obtaining Morphine sulphate from the manufacturer namely Govt. Opium Alkaloids Works (Neemuch/Ghazipur). 4) Necessary Transport Authorization (for movement of goods from Manufacturer to Buyer premises) is obtained from Local F.D.A authority is given along with Purchase Order and advance payment to Govt. Opium Alkaloid, so as to enable them to supply the active drug. Based on the availability of drug the Govt. Opium Alkaloid executes the order. The validity of the transport authorization is generally two month within which the order has to be executed. (it takes 8 to 10 days)

5) Intimation of receipt of drug is given to the State Excise Authority under the provisions of Medicine and Toiler Preparation Act. 6) The drug is then analyzed (One week) and subjected to manufacturing process so as to obtain the required Morphine tablets to execute the overseas order. 7) After completion of manufacturing process ( days), the necessary transport authorization to transport the finished product from the factory to nearest port of shipment is obtained from the Local F.D.A ( days) 8) The said transport authorization is send to Narcotic Commissioner at Gwalior, for obtained the required NOC to export Morphine tablets from India. 9) Meanwhile the State Excise duty payable on the finished product is discharged. 10) On receipt of NOC from The Narcotic Commissioner of India, the goods are released for shipment.

Nishant Dale Export - Department Cipla Ltd, Mumbai Ph: Mobile: +91 –

Oral morphine production in Nepal Explore the possibility of production oral morphine in Nepal. Discussion with Nepalese drug company

Oral morphine production in Nepal Sharing of morphine consumption data Humanitarian approach Business nationally & (Internationally!)

Oral morphine production in Nepal National Healthcare Ltd.,Nepalese Drug Company willing start manufacture of oral morphine when we assured help from government side.

Steps They applied to Department of Drug Administration (DDA) for manufacturing license of morphine syrup. 6 months duration of stability testing National Medicine Laboratory Marketing license

Oral morphine production in Nepal Morphine syrup in 2009

Oral morphine production in Nepal Starting manufacturing immediate release morphine tablet since 2011.

New problem 200,000 morphine SR tabs imported in August 21 st 2008, with expiry date July 2011 Stock balance 97,130 in July 15 th,2011

SR morphine production in Nepal Commitment to continue production of immediate release tablet. Morphine SR Tablet in 2012.

Morphine Tab(10mg) PR

Morphine Tab 30mg (PR)2012

Morphine sulphate Switzerland Iran India

Nepalese Association of Palliative Care NAPCare 22 representatives from 13 different institutions had joint meeting in July 2009 NAPCare Officially registered 16 th December, 2009 and 11 member body was formed.

Groups involved to form NAPC 1) Bir Hospital 2)Bhaktapur Cancer Hospital 10)Hospice Nepal 3)TU Teaching Hospital 11)Nepal Institute of Health Science 4)Stupa Community Hospital 12)B.P.K.M. Cancer Hospital 5)BPKM Cancer Hospital 13)Sechen Hospice 6)OM Hospital 7)Pashupati Aryaghat Service Center 8)Thankot Hospice Center 9)Nepalese Network Cancer Treatment and Research

Nepalese Association of Palliative Care S.N.NamePositionOrganization 1Dr. Pradeep VaidyaPresidentHospice Nepal 2Dr. Bijaya Raj NeupaneVice PresidentBPKM Cancer Hospital 3Dr. Sudip ShresthaVice PresidentBhaktapur C. Hospital 4Dr. Bishnu Dutta PaudelSecretaryBir Hospital 5Radha Piyari Vice SecretaryNNCTR 6Ms. Narbada KhanalTresurerNIHS 7 Ms. Usha ThapaVice TresurerBPKMCH 8Dr. Yogendra Prasad SinghMemberT.U.Teaching Hospital 9Dr. Surendra B. BadeMemberNNCTR 10Mr. Padma Raj BharatiMemberP.A. Service Center 11Dr. Bal Kumar SubbaMemberSechen Hospice

Educational activities for medical staff at major hospitals and hospices on pain relief and palliative care. Cancer pain Relief topic was included in March 2010 National Cancer Conference & first ASCO MCMC course. Knowledge & Attitude

Educational activities Four weeks training in 2009 in capital six weeks training in 2010 & 2011 out of capital

Dr. Eric in Nepal to support different activities

Fellow talking about Pain

Palliative care conference(2009)

Prescription Form for morphine & opiods

Annual consumption morphine in Nepal YearMorphine in KG

Conclusion All forms of morphine available in Nepal People are working jointly Knowledge and awareness of regarding opioid use has been improving.